- Home
- RGTI vs NYXH Comparison
RGTI vs NYXH Comparison
Compare RGTI & NYXH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RGTI
- NYXH
- Stock Information
- Founded
- RGTI 2013
- NYXH 2009
- Country
- RGTI United States
- NYXH Belgium
- Employees
- RGTI N/A
- NYXH N/A
- Industry
- RGTI Retail: Computer Software & Peripheral Equipment
- NYXH Medical/Dental Instruments
- Sector
- RGTI Technology
- NYXH Health Care
- Exchange
- RGTI Nasdaq
- NYXH Nasdaq
- Market Cap
- RGTI 285.0M
- NYXH 261.1M
- IPO Year
- RGTI N/A
- NYXH 2021
- Fundamental
- Price
- RGTI $11.40
- NYXH $8.00
- Analyst Decision
- RGTI Strong Buy
- NYXH Strong Buy
- Analyst Count
- RGTI 4
- NYXH 5
- Target Price
- RGTI $3.00
- NYXH $17.00
- AVG Volume (30 Days)
- RGTI 131.4M
- NYXH 37.4K
- Earning Date
- RGTI 11-12-2024
- NYXH 11-06-2024
- Dividend Yield
- RGTI N/A
- NYXH N/A
- EPS Growth
- RGTI N/A
- NYXH N/A
- EPS
- RGTI N/A
- NYXH N/A
- Revenue
- RGTI $11,892,000.00
- NYXH $5,668,079.00
- Revenue This Year
- RGTI N/A
- NYXH $37.10
- Revenue Next Year
- RGTI $47.00
- NYXH $418.12
- P/E Ratio
- RGTI N/A
- NYXH N/A
- Revenue Growth
- RGTI N/A
- NYXH 32.65
- 52 Week Low
- RGTI $0.66
- NYXH $4.00
- 52 Week High
- RGTI $10.68
- NYXH $20.00
- Technical
- Relative Strength Index (RSI)
- RGTI 86.92
- NYXH 42.46
- Support Level
- RGTI $2.88
- NYXH $7.86
- Resistance Level
- RGTI $7.96
- NYXH $8.81
- Average True Range (ATR)
- RGTI 1.51
- NYXH 0.46
- MACD
- RGTI 0.80
- NYXH 0.06
- Stochastic Oscillator
- RGTI 94.39
- NYXH 43.87
About RGTI Rigetti Computing Inc.
Rigetti Computing Inc is engaged in the business of full-stack quantum computing. Its proprietary quantum-classical infrastructure provides ultra-low latency integration with public and private clouds for high-performance practical quantum computing. The company has developed the industry's first multi-chip quantum processor for scalable quantum computing systems. Geographically, it derives a majority of its revenue from the United States.
About NYXH Nyxoah SA
Nyxoah SA is a health-technology company focused on the development and commercialization of solutions and services to treat sleep disordered breathing conditions. Nyxoah's solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe Obstructive Sleep Apnea (OSA), the common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke.